For treatment of: Riboxinum It is used cirrhosis of the liver, coronary heart disease, chronic hepatitis, cardiac arrhythmia, post-infarction condition.Riboxinum inosine
- For the treatment of organs: liver, heart.
- Appointment: cirrhosis of the liver, coronary heart disease, chronic hepatitis, cardiac arrhythmia, post-infarction condition.
- Indications for use:
IHD, myocardiodystrophy, condition after a myocardial infarction, congenital and acquired heart defects, heart rhythm disorders, especially with glycoside intoxication, myocarditis, dystrophic changes in the myocardium after heavy physical exertion and infectious diseases or due to endocrine disorders; hepatitis, cirrhosis of the liver, fatty liver dystrophy, including those caused by alcohol or drugs; prevention of leukopenia during radiation exposure; operations on an isolated kidney (as a means of pharmacological protection in the temporary absence of blood circulation in the operated organ).
Gout, hyperuricemia, hypersensitivity to inosine.
Active substance: inosine – 200 mg
Excipients: sugar, potato starch, titanium dioxide, water-soluble methylcellulose, tween-80, tropeolin O, stearic acid.
- Manufacturer: Ozon